Psychoactive substances like alcohol and caffeine may ease certain MS symptoms, but can make some symptoms worse, a study ...

Cantex and Headlamp Health are teaming up to accelerate the development of azeliragon for severe depression and fatigue in MS ...

Foralumab may help slow disability progression and ease fatigue in people with nonactive SPMS, per data from an early access ...

While columnist Ben Hofmeister admittedly is no expert on artificial intelligence and healthcare, he thinks it'll be good for MS research.

Enrollment has reached 50% in an ongoing study testing whether a PET tracer can reliably measure myelin damage in people with ...

The two main mouse models used to study myelin damage and repair in MS each replicate certain distinct biological features of ...

CMSC CEO Kathy Costello reflects on the progress made in MS care and what is still needed in the years to come.

Columnist Desiree Lama tells the people she loves in a letter that supporting someone with MS isn't about "fixing" them.

For columnist Ahna Crum, spending time in an MRI tube feels like simply another part of living with MS, which requires ...

CAR-M therapy LIB820 may deplete disease-driving B-cells in MS and other autoimmune diseases without severe side effects, new ...

The FDA agreed that the design of a Phase 3 trial testing privosegtor in optic neuritis could support a future approval ...

MRI and disability scores better identify cognitive decline in stable RRMS patients than blood biomarkers, according to a new ...